Christopher J. Hewitt
Papers
1
Total Citations
17
H-Index
1
About
Christopher J. Hewitt is a leading figure in the field of advanced therapeutic medicinal products (ATMPs), with a primary research focus on the scalable, automated manufacture of cell therapy products. His most cited work, "Needle to needle robot‑assisted manufacture of cell therapy products" (2022, 17 citations), addresses a critical bottleneck in the field: the transition from costly, high-risk manual cell expansion to fully automated, GMP-compliant production. Hewitt’s major contribution lies in designing a closed, robotic system that integrates every step from raw material to final product, dramatically reducing contamination risk and variability while enabling the large-scale production of high-quality cells needed for untreatable diseases. This work has significant implications for making life-saving therapies more accessible and affordable. Beyond this flagship study, his research continues to push boundaries in bioprocess engineering and automation, earning him recognition as a pioneer in the manufacturing science of cell-based medicines. His impact is underscored by the growing citation of his work, reflecting its foundational role in shaping the future of ATMP production.
Research Focus
Key Achievements
Top Papers
- 1